β-Hydroxybutyrate suppresses colorectal cancer
2022 · Nature · 301 citations
https://doi.org/10.1038/s41586-022-04649-6
B
Bryson W. Katona
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
281
Papers
4.2K
Citations
32
h-index
69
i10-index
Bryson W. Katona is an academic researcher from Hospital of the University of Pennsylvania. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics. The author has an h-index of 32, co-authored 239 publications.
ORCID: 0000-0001-8186-9119Papers by this author
worksNCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
2021 · PubMed · 154 citations
https://doi.org/10.1164/jnccn.2021.0048
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
2015 · Cancer Cell · 84 citations
https://doi.org/10.1016/j.ccell.2015.09.005
Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines
2008 · Journal of Biological Chemistry · 80 citations
https://doi.org/10.1074/jbc.m805804200
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology
2024 · Journal of the National Comprehensive Cancer Network · 69 citations
https://doi.org/10.6004/jnccn.2024.0061
Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment
2023 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-023-43746-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat